Hillebrand G - Search Results

1

Ten years' experience with cyclosporine monotherapy after renal transplantation.

Hillebrand G, Schneeberger H, Schleibner S, Krumme D, Hillebrand C, Burkhardt K, Hacker H, Illner WD, Land W. Hillebrand G, et al. Among authors: hillebrand c. Transplant Proc. 1993 Feb;25(1 Pt 1):513-4. Transplant Proc. 1993. PMID: 8438395 No abstract available.

2

Renal transplantation: progress and prospects.

Hillebrand GF, Land W. Hillebrand GF, et al. Artif Organs. 1996 May;20(5):403-7. doi: 10.1111/j.1525-1594.1996.tb04523.x. Artif Organs. 1996. PMID: 8725618 Review.

3

No clinical evidence of hyperlipidemia as a risk factor for chronic renal allograft failure.

Hillebrand GF, Schlosser S, Schneeberger H, Lorenz B, Zanker B, Samtleben W, Land W. Hillebrand GF, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):1391-2. doi: 10.1016/s0041-1345(98)02039-9. Transplant Proc. 1999. PMID: 10083615 No abstract available.

4

Calcineurin inhibitor-free immunosuppressive strategy in elderly recipients of renal allografts from deceased donors: 1-year results from a prospective single center trial.

Arbogast HP, Hoffmann JN, Illner WD, Hillebrand GF, Fischereder M, Jauch KW, Land W. Arbogast HP, et al. Among authors: hillebrand gf. Transplant Proc. 2009 Jul-Aug;41(6):2529-32. doi: 10.1016/j.transproceed.2009.06.151. Transplant Proc. 2009. PMID: 19715968

5

Chronic Epstein-Barr virus reactivation after renal transplantation: immunosuppression with cyclosporine versus azathioprine.

Hillebrand G, Castro LA, Schleibner S, Land W, Gurland HJ. Hillebrand G, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):2179-80. Transplant Proc. 1987. PMID: 2856280 No abstract available.

6

Monitoring of interferon-alpha 2-treated renal transplant patients using fine-needle aspiration biopsy.

Dendorfer U, Hammer C, Schleibner S, Castro LA, Hillebrand G, Land W, Brendel W. Dendorfer U, et al. Among authors: hillebrand g. Transplant Proc. 1987 Feb;19(1 Pt 3):2187-9. Transplant Proc. 1987. PMID: 2856281 No abstract available.

7

Is withdrawal of steroids hazardous to cadaveric renal transplants under treatment with cyclosporine?

Hillebrand G, Krumme D, Schleibner S, Land W, Gurland HJ. Hillebrand G, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):126-9. Transplant Proc. 1988. PMID: 3291225 No abstract available.

8

Immunosuppressive quadruple drug induction therapy sensitized renal allograft recipients.

Schleibner S, Hillebrand G, Illner WD, Höhnke C, Steitz HO, Land W. Schleibner S, et al. Among authors: hillebrand g. Transplant Proc. 1987 Oct;19(5):3752-3. Transplant Proc. 1987. PMID: 3313910 No abstract available.

9

Combined kidney/pancreas transplantation--poor long-term outcome of renal grafts.

Hillebrand G, Castro LA, Landgraf R, Schleibner S, Illner WD, Abendroth D, Land W. Hillebrand G, et al. Transplant Proc. 1987 Oct;19(5):3909-10. Transplant Proc. 1987. PMID: 3313960 No abstract available.

10

MRP8/14-positive macrophages as early acute cellular rejection markers, and soluble MRP8/14 and increased expression of adhesion molecules following renal transplantation.

Burkhardt K, Bösnecker A, Hillebrand G, Hofmann GO, Schneeberger H, Burmeister G, Land W, Gurland HJ. Burkhardt K, et al. Among authors: hillebrand g. Transplant Proc. 1995 Feb;27(1):890-1. Transplant Proc. 1995. PMID: 7533437 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters